You can buy or sell RVMD and other stocks, options, ETFs, and crypto commission-free!
Revolution Medicines, Inc. Common Stock, also called Revolution Medicines, is a clinical-stage precision oncology company focused on developing novel targeted therapies. Read More It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.
Redwood City, California
52 Week High
52 Week Low